AI Slashes Drug Discovery Timelines to Under 18 Months

Generative AI is transforming the pharmaceutical industry by drastically shortening drug discovery timelines ^[1]. Traditional methods usually take more than a decade to move a drug from concept to clinical trials ^[1]. New advancements allow researchers to complete this work in months instead of years ^[1].

Insilico Medicine recently demonstrated this efficiency by moving drug candidates to Phase 2 clinical trials in under 18 months ^[1]. This rapid progress marks a major shift in how companies approach medical research and development ^[1]. The use of AI agents helps streamline early-stage testing and data analysis ^[1].